New meningitis shot proves its mettle in final trial
NCT ID NCT04368429
Summary
This study tested a new vaccine designed to protect against four major strains of meningococcal disease (A, C, Y, W) in healthy people aged 2 to 55. Researchers compared the new shot to an already approved vaccine to see if it triggered a similar or better immune response. The main goal was to show the new vaccine works just as well, while also checking for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL IMMUNISATION (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 3920001
Koganeishi, Japan
-
Investigational Site Number 3920002
Shinjuku-Ku, Japan
-
Investigational Site Number 3920003
Shinjuku-Ku, Japan
-
Investigational Site Number 3920004
Nagoya, Japan
Conditions
Explore the condition pages connected to this study.